Wolverine Asset Management LLC Clovis Oncology, Inc. Call Options Transaction History

Wolverine Asset Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $320,250 - $641,750	-25,000 Reduced 27.78%	65,000 $966,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $1.5 Million - $2.57 Million	85,000 Added 1700.0%	90,000 $2.23 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $185,064 - $274,560	4,400 Added 733.33%	5,000 $227,000
Q2 2017 Aug 14, 2017	BUY	N/A	600	600 $56,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.